
Teneligliptin (20mg) + Metformin (500mg)
Active composition
+1 more active ingredient
Teneligliptin inhibits DPP-4, increasing incretin levels and enhancing insulin secretion.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Neliptin M 500 Tablet ER is a combined pharmaceutical formulation, containing 500mg Metformin and 20mg Teneligliptin. This medication is primarily indicated for the management of type 2 diabetes mellitus, in both mono- and combination therapy settings. Metformin, a biguanide, works by decreasing glucose production in the liver, while Teneligliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, enhances the release of insulin and reduces glucagon secretion from the pancreas. The extended-release (ER) formulation ensures a sustained release of the active ingredients, aiming for optimal glycemic control and minimizing the risk of hypoglycemia. As with any medication, it should be used under professional medical supervision, and patients should be closely monitored for its therapeutic effectiveness and potential side effects.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Neliptin M 500 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Neliptin M 500 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Neliptin M 500 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Neliptin M 500 Tablet ER may be needed. Please consult your doctor. Use of Neliptin M 500 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
It is not known whether Neliptin M 500 Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Neliptin M 500 Tablet ER is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Neliptin M 500 Tablet ER

Metformin (500mg) + Teneligliptin (20mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Teneligliptin inhibits DPP-4, increasing incretin levels and enhancing insulin secretion.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Neliptin M 500 Tablet ER is a combined pharmaceutical formulation, containing 500mg Metformin and 20mg Teneligliptin. This medication is primarily indicated for the management of type 2 diabetes mellitus, in both mono- and combination therapy settings. Metformin, a biguanide, works by decreasing glucose production in the liver, while Teneligliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, enhances the release of insulin and reduces glucagon secretion from the pancreas. The extended-release (ER) formulation ensures a sustained release of the active ingredients, aiming for optimal glycemic control and minimizing the risk of hypoglycemia. As with any medication, it should be used under professional medical supervision, and patients should be closely monitored for its therapeutic effectiveness and potential side effects.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Neliptin M 500 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Neliptin M 500 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Neliptin M 500 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Neliptin M 500 Tablet ER may be needed. Please consult your doctor. Use of Neliptin M 500 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
It is not known whether Neliptin M 500 Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Neliptin M 500 Tablet ER is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Neliptin M 500 Tablet ER













